Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Gregory

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1990
Characterization of three monoclonal antibodies that recognize the interferon alpha 2 receptorO R Colamonici, F D'Alessandro, M O Diaz, et al.
Leukemia & Lymphoma|June 28, 2001
Mitoxantrone and fludarabine in the treatment of patients with non-Hodgkin's lymphoma failing primary therapy with a doxorubicinor mitoxantrone-containing regimenS A Gregory, J Vose, M Modiano, et al.
Journal of Virology|December 1, 1992
An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1R Collman, J W Balliet, S A Gregory, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1996
T cell activation is regulated by voltage-dependent and calcium-activated potassium channelsR K Rader, L E Kahn, G D Anderson, et al.
Cancer Letters|July 14, 1999
Correlation of tumor necrosis factor alpha (TNF alpha) with high Caspase 3-like activity in myelodysplastic syndromesS D Mundle, S Reza, A Ali, et al.
Leukemia|February 22, 2008
NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients: implication of HLA-GG Maki, G M Hayes, A Naji, et al.
The Journal of Clinical Investigation|June 1, 1996
Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritisG D Anderson, S D Hauser, K L McGarity, et al.
Leukemia & Lymphoma|June 28, 2001
Effectiveness of interferon-alfa and mid-cycle chemotherapy added to an anthracycline-based regimen in the treatment of aggressive non-Hodgkin's lymphomaS H Enschede, H Shahidi, P Venugopal, et al.
Cytokines, Cellular & Molecular Therapy|December 7, 2000
Effect of interferon-alpha on CD20 antigen expression of B-cell chronic lymphocytic leukemiaS Sivaraman, P Venugopal, R Ranganathan, et al.
Leukemia & Lymphoma|December 31, 1997
Excessive proliferation matched by excessive apoptosis in myelodysplastic syndromes: the cause-effect relationshipA Raza, S Alvi, R Z Borok, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1990
Characterization of three monoclonal antibodies that recognize the interferon alpha 2 receptorO R Colamonici, F D'Alessandro, M O Diaz, et al.
Leukemia & Lymphoma|June 28, 2001
Mitoxantrone and fludarabine in the treatment of patients with non-Hodgkin's lymphoma failing primary therapy with a doxorubicinor mitoxantrone-containing regimenS A Gregory, J Vose, M Modiano, et al.
Journal of Virology|December 1, 1992
An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1R Collman, J W Balliet, S A Gregory, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1996
T cell activation is regulated by voltage-dependent and calcium-activated potassium channelsR K Rader, L E Kahn, G D Anderson, et al.
Cancer Letters|July 14, 1999
Correlation of tumor necrosis factor alpha (TNF alpha) with high Caspase 3-like activity in myelodysplastic syndromesS D Mundle, S Reza, A Ali, et al.
Leukemia|February 22, 2008
NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients: implication of HLA-GG Maki, G M Hayes, A Naji, et al.
The Journal of Clinical Investigation|June 1, 1996
Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritisG D Anderson, S D Hauser, K L McGarity, et al.
Leukemia & Lymphoma|June 28, 2001
Effectiveness of interferon-alfa and mid-cycle chemotherapy added to an anthracycline-based regimen in the treatment of aggressive non-Hodgkin's lymphomaS H Enschede, H Shahidi, P Venugopal, et al.
Cytokines, Cellular & Molecular Therapy|December 7, 2000
Effect of interferon-alpha on CD20 antigen expression of B-cell chronic lymphocytic leukemiaS Sivaraman, P Venugopal, R Ranganathan, et al.
Leukemia & Lymphoma|December 31, 1997
Excessive proliferation matched by excessive apoptosis in myelodysplastic syndromes: the cause-effect relationshipA Raza, S Alvi, R Z Borok, et al.
Pageof 8